Qualitative and Psychometric Evaluation of 29-Item Patient-Reported Outcomes Measurement Information System® to Assess General Health-Related Quality of Life in Patients With Moderately to Severely Active Inflammatory Bowel Disease.
Bruce E SandsJulian PanésBrian G FeaganHongyan ZhangMarion L VetterSusan D MathiasKuan-Hsiang Gary HuangJewel JohannsMatthew GerminaroAparna SahooNatalie A TerryChenglong HanPublished in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research (2024)
PROMIS-29 is valid, reliable, and responsive for assessing general health-related quality of life and treatment response in IBD clinical trials.